People · Operator
Named in public records as an officer, director or promoter · active 2016–2023 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| E5 Inc. | — | Other | Seed | $2.7M | $14.0M | 2023 |
| NeuroFx, Inc. | — | Biotechnology | Seed | $1.9M | $83.9M | 2016 |
Jennifer Rhodes at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jennifer Rhodes on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Karl Meyer | 1 | 3 |
| Scott A. Jones | 1 | 3 |
| Megan Gumbel | 1 | 1 |
| Joseph Shetterley | 1 | 1 |
| Brad L. Miller | 1 | 1 |
| Wade Lange | 1 | 1 |
| Keith L. March | 1 | 1 |
| Alexander Lange | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.